Entero Healthcare Solutions Limited has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding scheduled investor meetings. The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
Company officials will attend a virtual Investor Conference organized by Arihant Capital Markets Ltd. The meeting is scheduled for September 29, 2026, starting at 02:00 P.M. onwards. The interaction is classified as a Group Meeting.
Discussion Parameters
The company explicitly states that discussions during these interactions will be based solely on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed during these meetings.
Contingency Note
The disclosure includes a note that changes to the schedule may occur due to exigencies on the part of participants or the company.